Patrick Burgermeister
Molecular biologist, investor and futurist.
Patrick Burgermeister is an expert in life science investing with a double background in molecular biology (Biozentrum Basel) and business administration (HSG Sankt Gallen). He joined Kizoo in 2019 coming from the venture capital group BioMedPartners where he was one of the partners. Moreover, his industry career encompasses also banking (as a senior analyst for pharma/biotech) and pharma (as a senior portfolio manager at Novartis). Patrick supports various biotech companies as a director on their boards, was a successful business developer for early-stage biotech companies and led collaboration and licensing deals with public and private companies. He headed business development at several companies including Apeiron Biologics and BioVersys.
Visit website: https://www.lifespan.io/profile/patrick-burgermeister/
See also: KIZOO Technology Ventures - Company providing financing and its focus is on rejuvenation biotech
Details last updated 09-Sep-2020
Patrick Burgermeister is also referenced in the following:
Longevity Leaders World Congress 2022
26-Feb-2022 to 27-Feb-2022
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Patrick Burgermeister News
Reservoir Neuroscience secures $4M to rejuvenate the aging brain
KIZOO Technology Ventures - 18-Jan-2024
New therapies combat age-related brain diseases by restoring blood vessel heath
Read more...Revel pharmaceutics raised $8.4M to push enzyme therapies to clinic
KIZOO Technology Ventures - 17-Mar-2022
Funds will be used to develop enzymes that repair collagen and reverse ageing or disease
Read more...